As you know, DIA has announced that Worldwide Executive Director Paul Pomerantz will leave his position with DIA effective March 3, 2013. Paul has accepted a position as CEO for the American Society of Anesthesiologists based in Chicago and Washington, D.C. This is an exciting opportunity to lead an association of health care professionals that he felt he could not decline.
Paul’s leadership during his three years with DIA has laid the groundwork for our current and future success. Under his direction, we have achieved rapid global expansion and significantly increased our stakeholder relationships. DIA is becoming a world-class, knowledge-driven organization. We thank Paul for his service and wish him the best of success in his new position.
While Paul will be missed, we are confident in the ability of our Board of Directors, Global Management Team, and staff to manage a smooth transition and continue building on our 50-year history. We will soon start a search for the new executive director. I can assure you that the board and staff are committed to continuing our direction and programs in the service of our members and stakeholders. In the meantime, please let me know if you have any concerns.
I thank you for your support and look forward to continuing to work with you.
Ling Su, Ph.D.
President, DIA Board of Directors
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; and Beijing, China.
Contact: Judy Connors